VYNE declares special cash dividend of $0.38/share in connection with Yarrow merger

VYNE Therapeutics Inc.

Estimated aggregate $16.5M special cash dividend ($0.38/share) declared; record date July 22, 2026.
Dividend conditioned on closing of merger with Yarrow Bioscience; expected close on/about July 24, 2026.
Stockholder vote on merger scheduled for July 16, 2026; dividend payable after close.
Per-share amount based on 42,989,506 shares and equivalents outstanding as of July 9, 2026.
Actual distribution may be higher or lower than estimate; payment to transfer agent on July 23, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.